{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:46:33Z","timestamp":1772117193901,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejca.2018.01.085","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T11:31:55Z","timestamp":1521545515000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer"],"prefix":"10.1016","volume":"93","author":[{"given":"Shi-Xiu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LV-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Lei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Bang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-Hua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Long","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-Xi","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-Xian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2018.01.085_bib1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Enzinger","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2018.01.085_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2018.01.085_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2018.01.085_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.bjc.6601461","article-title":"Definitive chemoradiation in patients with inoperable oesophageal carcinoma","volume":"90","author":"Crosby","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2018.01.085_bib5","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.2014.56.7156","article-title":"Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer","volume":"32","author":"Sudo","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.01.085_bib6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.01.085_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2016.04.042","article-title":"Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis","volume":"120","author":"Chen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2018.01.085_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.01.085_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.01.085_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cncr.22445","article-title":"Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2018.01.085_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ijc.21454","article-title":"EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus","volume":"118","author":"Hanawa","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2018.01.085_bib12","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1158\/0008-5472.CAN-04-3547","article-title":"Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)","volume":"65","author":"Chinnaiyan","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2018.01.085_bib13","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/cncr.25602","article-title":"A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus","volume":"117","author":"Ilson","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2018.01.085_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000351617","article-title":"Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trial","volume":"85","author":"Iyer","year":"2013","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2018.01.085_bib15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ijrobp.2009.10.012","article-title":"Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma","volume":"78","author":"Li","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.01.085_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000658-199409000-00012","article-title":"Radical lymph node dissection for cancer of the thoracic esophagus","volume":"220","author":"Akiyama","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2018.01.085_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2014.11.045","article-title":"Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation?","volume":"357","author":"Jiang","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2018.01.085_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/dote.12471","article-title":"Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature","author":"Du","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejca.2018.01.085_bib19","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/j.ijrobp.2011.04.032","article-title":"Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma","volume":"81","author":"Hsu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.01.085_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2018.01.085_bib21","doi-asserted-by":"crossref","first-page":"57310","DOI":"10.18632\/oncotarget.9809","article-title":"A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2018.01.085_bib22","series-title":"Handbook of statistics in clinical Oncology","first-page":"199","article-title":"Factorial designs with time-to-event endpoints","author":"Stephanie","year":"2012"},{"key":"10.1016\/j.ejca.2018.01.085_bib23","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1002\/sim.5762","article-title":"Model selection in competing risks regression","volume":"32","author":"Kuk","year":"2013","journal-title":"Stat Med"},{"issue":"suppl 3","key":"10.1016\/j.ejca.2018.01.085_bib24","article-title":"The initial report of RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery","volume":"32","author":"Suntharalingam","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.01.085_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4149\/neo_2012_065","article-title":"Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas","volume":"59","author":"Smilek","year":"2012","journal-title":"Neoplasma"},{"key":"10.1016\/j.ejca.2018.01.085_bib26","first-page":"729","article-title":"Expression and significance of epidermal growth factor receptor and its variant III in human esophageal carcinoma","volume":"19","author":"Liu","year":"2009","journal-title":"China Oncology"},{"key":"10.1016\/j.ejca.2018.01.085_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijrobp.2015.02.005","article-title":"Adding erlotinib to chemoradiation improves overall survival but not progression-free survival in stage III non-small cell lung cancer","volume":"92","author":"Komaki","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.01.085_bib28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/cncr.28471","article-title":"Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer","volume":"120","author":"Nogueira-Rodrigues","year":"2014","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918301199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918301199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T19:07:48Z","timestamp":1603998468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918301199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":28,"alternative-id":["S0959804918301199"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.01.085","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.01.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}